Cargando…
Inhaled nitric oxide in premature infants for preventing bronchopulmonary dysplasia: a meta-analysis
BACKGROUND: The effectiveness of nitric oxide (NO) in reducing the risk of bronchopulmonary dysplasia (BPD) remains debatable. In this study, we performed a meta-analysis to guide clinical decision-making regarding the significance of inhaled NO (iNO) on the potential occurrence and outcomes of BPD...
Autores principales: | Zheng, Yi, Wu, Qi, Han, Shuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053486/ https://www.ncbi.nlm.nih.gov/pubmed/36991371 http://dx.doi.org/10.1186/s12887-023-03923-4 |
Ejemplares similares
-
Circulating Endothelial Progenitor Cells Decrease in Infants with Bronchopulmonary Dysplasia and Increase after Inhaled Nitric Oxide
por: Qi, Yuanyuan, et al.
Publicado: (2013) -
Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia
por: Leclerc, F., et al.
Publicado: (1994) -
Molecular Mechanism of Caffeine in Preventing Bronchopulmonary Dysplasia in Premature Infants
por: Tian, Congliang, et al.
Publicado: (2022) -
Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L., et al.
Publicado: (2014) -
Inhaled Bronchodilator Use for Infants with Bronchopulmonary
Dysplasia
por: Slaughter, Jonathan L, et al.
Publicado: (2014)